Nephrogen is a biotech company in New York City developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.

Biotechnology

Health Care

Therapeutics

Nephrogen

Demetri Maxim

Vivek Bhalla

George Church

Avnesh Thakor

Mark Kay

Terry Watnick

Ron Perrone

Jan Liphardt

This department provides expert guidance and insights to support decision-making and strategic planning.

Advisory Services

This department focuses on conducting scientific research and developing innovative solutions.

Research and Development

Nephrogen

Org chart

Board & advisors

Teams

Advisory Services

Research and Development

Offices

Nephrogen

Org chart

Board & advisors

Teams

Advisory Services

Research and Development

Offices

Related companies